Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Cipla
AstraZeneca
Boehringer Ingelheim
Citi
Queensland Health
Merck
US Army
Dow

Generated: December 13, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LEVONORGESTREL

« Back to Dashboard

Clinical Trials for Levonorgestrel

Trial ID Title Status Sponsor Phase Summary
NCT00064766 Norplant and Irregular Bleeding/Spotting Unknown status Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Phase 4 Irregular or prolonged menstrual bleeding and/or spotting are common side effects in patients using progestin-only hormonal contraception such as levonorgestrel implants (Norplant). Doxycycline, a drug approved by the Food and Drug Administration (FDA) to treat gum disease, may reduce the occurrence of uterine bleeding and spotting in women who use Norplant. This study will evaluate the effects of doxycycline on uterine bleeding/spotting in women using Norplant.
NCT00117273 A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens Completed Duramed Research Phase 3 This is a randomized, open-label study to evaluate pituitary ovarian suppression in healthy, reproductive-aged women using three different regimens of oral contraceptives (OCs). Two extended regimen OCs, Seasonale (levonorgestrel/ethinyl estradiol 0.15/0.03 mg for 84 days followed by 7 days of placebo), and Seasonique (levonorgestrel/ethinyl estradiol 0.15/0.03 mg for 84 days followed by 7 days of ethinyl estradiol 0.01 mg), and a 28-day regimen OC, Portia (levonorgestrel/ethinyl estradiol 0.15/0.03 mg for 21 days followed by 7 days of placebo).
NCT00128934 Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder Completed Wyeth is now a wholly owned subsidiary of Pfizer Phase 3 The purpose of this study is to determine whether levonorgestrel (LNG)/ethinyl estradiol (EE) is effective in treating the symptoms of severe premenstrual syndrome (PMS).
NCT00131885 Effects of St. John's Wort on the Oral Contraceptive Hormone Levonorgestrel Completed National Center for Complementary and Integrative Health (NCCIH) Phase 4 This study will determine the effects of St. John's wort, a common herbal remedy, on metabolism of the female contraceptive hormone levonorgestrel.
NCT00131885 Effects of St. John's Wort on the Oral Contraceptive Hormone Levonorgestrel Completed University of Utah Phase 4 This study will determine the effects of St. John's wort, a common herbal remedy, on metabolism of the female contraceptive hormone levonorgestrel.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Levonorgestrel

Condition Name

Condition Name for Levonorgestrel
Intervention Trials
Contraception 66
Healthy 19
HIV 10
Endometriosis 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Levonorgestrel
Intervention Trials
Emergencies 15
Hemorrhage 14
Menorrhagia 9
Endometriosis 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Levonorgestrel

Trials by Country

Trials by Country for Levonorgestrel
Location Trials
United States 382
Germany 47
Canada 26
China 23
Mexico 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Levonorgestrel
Location Trials
California 21
Pennsylvania 21
Florida 20
Ohio 18
Colorado 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Levonorgestrel

Clinical Trial Phase

Clinical Trial Phase for Levonorgestrel
Clinical Trial Phase Trials
Phase 4 42
Phase 3 36
Phase 2/Phase 3 6
[disabled in preview] 25
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Levonorgestrel
Clinical Trial Phase Trials
Completed 103
Recruiting 35
Not yet recruiting 18
[disabled in preview] 26
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Levonorgestrel

Sponsor Name

Sponsor Name for Levonorgestrel
Sponsor Trials
Bayer 39
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 11
Wyeth is now a wholly owned subsidiary of Pfizer 8
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Levonorgestrel
Sponsor Trials
Other 159
Industry 105
NIH 23
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Deloitte
Covington
Chubb
Cipla
McKesson
Cerilliant
Cantor Fitzgerald
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.